In Brief: VimRx
Executive Summary
VimRx: GeneLogic Chief Operating Officer Richard Kouri, PhD, named CEO of VimRx Genomics, a genomics research collaboration 90% owned by VimRx and 10% owned by Columbia University...
VimRx: GeneLogic Chief Operating Officer Richard Kouri, PhD, named CEO of VimRx Genomics, a genomics research collaboration 90% owned by VimRx and 10% owned by Columbia University.... |